Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (8): 640-646.DOI: 10.3969/j.issn.1673-8640.2016.08.002
• Orginal Article • Previous Articles Next Articles
LI Xin, WANG Di, YANG Chun, XU Jiancheng
Received:
2015-11-19
Online:
2016-08-31
Published:
2016-09-01
CLC Number:
LI Xin, WANG Di, YANG Chun, XU Jiancheng. Reference intervals of serum bilirubin for Han children in Changchun[J]. Laboratory Medicine, 2016, 31(8): 640-646.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.08.002
年龄(岁) | 例数 | 男童 | 女童 |
---|---|---|---|
<1 | 240 | 120 | 120 |
1~ | 253 | 131 | 122 |
2~ | 247 | 127 | 120 |
3~ | 246 | 120 | 126 |
4~ | 247 | 127 | 120 |
5~ | 246 | 120 | 126 |
6~ | 250 | 124 | 126 |
7~ | 251 | 129 | 122 |
8~ | 252 | 132 | 120 |
9~ | 248 | 128 | 120 |
10~ | 249 | 129 | 120 |
11~ | 252 | 127 | 125 |
12~ | 250 | 120 | 130 |
13~ | 245 | 123 | 122 |
14~ | 240 | 120 | 120 |
合计 | 3 716 | 1 877 | 1 839 |
年龄(岁) | 例数 | 男童 | 女童 |
---|---|---|---|
<1 | 240 | 120 | 120 |
1~ | 253 | 131 | 122 |
2~ | 247 | 127 | 120 |
3~ | 246 | 120 | 126 |
4~ | 247 | 127 | 120 |
5~ | 246 | 120 | 126 |
6~ | 250 | 124 | 126 |
7~ | 251 | 129 | 122 |
8~ | 252 | 132 | 120 |
9~ | 248 | 128 | 120 |
10~ | 249 | 129 | 120 |
11~ | 252 | 127 | 125 |
12~ | 250 | 120 | 130 |
13~ | 245 | 123 | 122 |
14~ | 240 | 120 | 120 |
合计 | 3 716 | 1 877 | 1 839 |
年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
---|---|---|---|---|---|---|---|---|---|
<1 | 男 | 1.90(1.56~2.24) | 4.75(4.10~5.10) | 10.20(9.31~10.89) | 7~ | 女 | 2.85(2.63~4.17) | 7.50(6.98~8.02) | 14.59(13.73~15.07) |
女 | 1.80(1.18~2.42) | 5.60(4.93~6.07) | 13.04(1.97~15.03) | 8~ | 男 | 2.70(2.54~3.26) | 7.40(6.71~8.09) | 16.44(13.52~17.88) | |
1~ | 男 | 2.20(1.99~2.41) | 5.10(4.80~5.40) | 11.67(10.86~12.34) | 女 | 3.81(3.08~4.52) | 8.35(7.69~8.91) | 21.00(16.29~25.31) | |
女 | 2.42(2.37~2.83) | 5.75(5.18~6.22) | 12.96(11.04~13.96) | 9~ | 男 | 3.50(3.23~3.77) | 7.15(6.27~7.73) | 14.51(13.14~15.26) | |
2~ | 男 | 2.58(2.54~3.26) | 6.00(5.47~6.53) | 12.36(10.57~13.03) | 女 | 3.27(2.56~4.04) | 8.60(8.20~9.00) | 16.73(15.33~18.07) | |
女 | 2.51(1.94~3.06) | 6.55(5.78~7.22) | 16.39(13.37~18.43) | 10~ | 男 | 3.28(2.81~4.19) | 8.00(7.61~8.39) | 15.10(13.93~15.67) | |
3~ | 男 | 2.31(1.53~3.07) | 5.80(5.46~6.14) | 11.19(9.81~11.59) | 女 | 3.10(2.69~3.51) | 8.10(7.11~8.89) | 17.29(14.37~19.63) | |
年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
女 | 2.65(2.35~3.45) | 6.50(5.89~7.11) | 15.08(12.71~16.29) | 11~ | 男 | 2.92(2.22~3.78) | 7.60(6.98~8.22) | 17.92(14.78~20.42) | |
4~ | 男 | 2.60(2.43~2.77) | 5.90(5.67~6.13) | 12.44(11.20~13.20) | 女 | 3.33(2.99~4.01) | 8.20(7.87~8.53) | 16.17(14.86~17.14) | |
女 | 2.70(2.17~3.23) | 6.60(5.94~7.26) | 17.15(12.38~17.82) | 12~ | 男 | 3.90(2.98~4.82) | 8.35(7.30~9.10) | 19.87(16.41~20.99) | |
5~ | 男 | 3.00(2.60~3.40) | 5.90(5.54~6.26) | 11.09(9.58~11.82) | 女 | 1.88(1.36~2.84) | 8.70(7.64~9.56) | 19.77(18.28~21.12) | |
女 | 3.52(3.12~4.08) | 6.25(5.77~6.63) | 12.51(11.39~12.81) | 13~ | 男 | 1.55(1.35~2.65) | 8.10(7.20~9.00) | 21.34(16.63~24.97) | |
6~ | 男 | 3.03(2.92~3.48) | 6.30(5.70~6.90) | 12.25(9.85~12.55) | 女 | 2.00(1.76~2.24) | 6.60(5.78~7.22) | 15.86(14.28~16.32) | |
女 | 3.52(3.08~4.12) | 7.80(7.20~8.20) | 16.48(14.65~17.15) | 14~ | 男 | 1.50(1.10~1.90) | 8.20(7.32~8.88) | 19.08(15.58~20.82) | |
7~ | 男 | 2.95(2.74~3.46) | 6.70(6.18~7.22) | 15.43(12.51~17.89) | 女 | 2.05(1.43~2.77) | 6.60(6.10~7.10) | 13.60(12.85~14.35) |
年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
---|---|---|---|---|---|---|---|---|---|
<1 | 男 | 1.90(1.56~2.24) | 4.75(4.10~5.10) | 10.20(9.31~10.89) | 7~ | 女 | 2.85(2.63~4.17) | 7.50(6.98~8.02) | 14.59(13.73~15.07) |
女 | 1.80(1.18~2.42) | 5.60(4.93~6.07) | 13.04(1.97~15.03) | 8~ | 男 | 2.70(2.54~3.26) | 7.40(6.71~8.09) | 16.44(13.52~17.88) | |
1~ | 男 | 2.20(1.99~2.41) | 5.10(4.80~5.40) | 11.67(10.86~12.34) | 女 | 3.81(3.08~4.52) | 8.35(7.69~8.91) | 21.00(16.29~25.31) | |
女 | 2.42(2.37~2.83) | 5.75(5.18~6.22) | 12.96(11.04~13.96) | 9~ | 男 | 3.50(3.23~3.77) | 7.15(6.27~7.73) | 14.51(13.14~15.26) | |
2~ | 男 | 2.58(2.54~3.26) | 6.00(5.47~6.53) | 12.36(10.57~13.03) | 女 | 3.27(2.56~4.04) | 8.60(8.20~9.00) | 16.73(15.33~18.07) | |
女 | 2.51(1.94~3.06) | 6.55(5.78~7.22) | 16.39(13.37~18.43) | 10~ | 男 | 3.28(2.81~4.19) | 8.00(7.61~8.39) | 15.10(13.93~15.67) | |
3~ | 男 | 2.31(1.53~3.07) | 5.80(5.46~6.14) | 11.19(9.81~11.59) | 女 | 3.10(2.69~3.51) | 8.10(7.11~8.89) | 17.29(14.37~19.63) | |
年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) | 年龄 (岁) | 性别 | P2.5 (90% CI) | P50 (90% CI) | P97.5 (90% CI) |
女 | 2.65(2.35~3.45) | 6.50(5.89~7.11) | 15.08(12.71~16.29) | 11~ | 男 | 2.92(2.22~3.78) | 7.60(6.98~8.22) | 17.92(14.78~20.42) | |
4~ | 男 | 2.60(2.43~2.77) | 5.90(5.67~6.13) | 12.44(11.20~13.20) | 女 | 3.33(2.99~4.01) | 8.20(7.87~8.53) | 16.17(14.86~17.14) | |
女 | 2.70(2.17~3.23) | 6.60(5.94~7.26) | 17.15(12.38~17.82) | 12~ | 男 | 3.90(2.98~4.82) | 8.35(7.30~9.10) | 19.87(16.41~20.99) | |
5~ | 男 | 3.00(2.60~3.40) | 5.90(5.54~6.26) | 11.09(9.58~11.82) | 女 | 1.88(1.36~2.84) | 8.70(7.64~9.56) | 19.77(18.28~21.12) | |
女 | 3.52(3.12~4.08) | 6.25(5.77~6.63) | 12.51(11.39~12.81) | 13~ | 男 | 1.55(1.35~2.65) | 8.10(7.20~9.00) | 21.34(16.63~24.97) | |
6~ | 男 | 3.03(2.92~3.48) | 6.30(5.70~6.90) | 12.25(9.85~12.55) | 女 | 2.00(1.76~2.24) | 6.60(5.78~7.22) | 15.86(14.28~16.32) | |
女 | 3.52(3.08~4.12) | 7.80(7.20~8.20) | 16.48(14.65~17.15) | 14~ | 男 | 1.50(1.10~1.90) | 8.20(7.32~8.88) | 19.08(15.58~20.82) | |
7~ | 男 | 2.95(2.74~3.46) | 6.70(6.18~7.22) | 15.43(12.51~17.89) | 女 | 2.05(1.43~2.77) | 6.60(6.10~7.10) | 13.60(12.85~14.35) |
年龄 (岁) | 例数 | TBil(µmol/L) | CBil(µmol/L) | UBil(µmol/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
参考区间 | 90%CI | 参考区间 | 90%CI | 参考区间 | 90%CI | |||||||
P2.5 | P97.5 | P2.5 | P97.5 | P2.5 | P97.5 | |||||||
<1 | 240 | 1.90~11.33 | 1.52~2.28 | 9.82~12.78 | 0.90~3.41 | 0.79~1.01 | 3.00~3.80 | 0.60~9.31 | 0.31~0.89 | 8.16~10.44 | ||
1 | 253 | 2.34~12.03 | 2.22~2.58 | 11.29~12.51 | 0.84~3.30 | 0.72~1.08 | 3.08~3.52 | 1.17~8.70 | 0.93~1.67 | 8.12~9.28 | ||
2~5及 6(男) | 1 110 | 2.80~12.82 | 2.64~2.96 | 12.28~13.32 | 1.00~3.60 | 0.94~1.06 | 3.45~3.75 | 1.60~9.72 | 1.52~1.68 | 9.16~10.24 | ||
6(女) 及7 | 377 | 3.25~15.37 | 3.02~4.58 | 14.30~16.10 | 0.95~4.46 | 0.84~1.16 | 4.11~4.69 | 1.80~11.25 | 1.60~2.00 | 10.30~12.10 | ||
8~11 | 1 001 | 3.20~16.60 | 2.95~3.45 | 16.01~17.19 | 1.20~4.70 | 1.12~1.28 | 4.45~4.95 | 1.80~12.20 | 1.66~1.94 | 11.62~12.78 | ||
12 | 250 | 2.41~19.77 | 1.71~3.69 | 18.48~20.92 | 1.10~5.17 | 0.91~1.29 | 4.90~5.30 | 1.16~14.95 | 0.62~1.98 | 13.97~15.63 | ||
13~14 | 485 | 1.80~16.33 | 1.49~2.11 | 14.44~18.16 | 0.90~4.60 | 0.81~0.99 | 4.44~4.76 | 0.70~12.62 | 0.46~0.94 | 10.92~14.28 |
年龄 (岁) | 例数 | TBil(µmol/L) | CBil(µmol/L) | UBil(µmol/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
参考区间 | 90%CI | 参考区间 | 90%CI | 参考区间 | 90%CI | |||||||
P2.5 | P97.5 | P2.5 | P97.5 | P2.5 | P97.5 | |||||||
<1 | 240 | 1.90~11.33 | 1.52~2.28 | 9.82~12.78 | 0.90~3.41 | 0.79~1.01 | 3.00~3.80 | 0.60~9.31 | 0.31~0.89 | 8.16~10.44 | ||
1 | 253 | 2.34~12.03 | 2.22~2.58 | 11.29~12.51 | 0.84~3.30 | 0.72~1.08 | 3.08~3.52 | 1.17~8.70 | 0.93~1.67 | 8.12~9.28 | ||
2~5及 6(男) | 1 110 | 2.80~12.82 | 2.64~2.96 | 12.28~13.32 | 1.00~3.60 | 0.94~1.06 | 3.45~3.75 | 1.60~9.72 | 1.52~1.68 | 9.16~10.24 | ||
6(女) 及7 | 377 | 3.25~15.37 | 3.02~4.58 | 14.30~16.10 | 0.95~4.46 | 0.84~1.16 | 4.11~4.69 | 1.80~11.25 | 1.60~2.00 | 10.30~12.10 | ||
8~11 | 1 001 | 3.20~16.60 | 2.95~3.45 | 16.01~17.19 | 1.20~4.70 | 1.12~1.28 | 4.45~4.95 | 1.80~12.20 | 1.66~1.94 | 11.62~12.78 | ||
12 | 250 | 2.41~19.77 | 1.71~3.69 | 18.48~20.92 | 1.10~5.17 | 0.91~1.29 | 4.90~5.30 | 1.16~14.95 | 0.62~1.98 | 13.97~15.63 | ||
13~14 | 485 | 1.80~16.33 | 1.49~2.11 | 14.44~18.16 | 0.90~4.60 | 0.81~0.99 | 4.44~4.76 | 0.70~12.62 | 0.46~0.94 | 10.92~14.28 |
[1] | 王建中. 实验诊断学[M]. 2版. 北京:北京大学医学出版社,2010:155-157. |
[2] | CERIOTTI F,HENNY J,QUERALTO J,et al.Common reference intervals for aspartate aminotransferase (AST),alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum:results from an IFCC multicenter study[J]. Clin Chem Lab Med,2010,48(11):1593-1601. |
[3] | Clinical and Laboratory Standards Institute,International Federation of Clinical Chemistry and Laboratory Medicine. Defining,establishing,and verifying the reference intervals in a clinical laboratory[S]. C28-A3,CLSI and IFCC,2008. |
[4] | COLANTONIO DA,KYRIAKOPOULOU L,CHAN MK,et al.Closing the gaps in pediatric laboratory reference intervals:a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children[J]. Clin Chem,2012,58(5):854-868. |
[5] | MU R,CHEN W,PAN B,et al.First definition of reference intervals of liver function tests in China:a large-population-based multi-center study about healthy adults[J]. PLoS One,2013,8(9):e72916. |
[6] | BLASUTIG IM,JUNG B,KULASINGAM V,et al.Analytical evaluation of the VITROS 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals[J]. Clin Biochem,2010,43(13-14):1039-1044. |
[7] | KULASINGAM V,JUNG BP,BLASUTIG IM,et al.Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer-a CALIPER pilot study[J]. Clin Biochem,2010,43(13-14):1045-1050. |
[8] | 陈大鹏,陈元,刘来成,等. 重庆地区学龄前和学龄后健康儿童常用肝肾功能检验项目参考区间的调查[J]. 重庆医科大学学报,2015,40(5):785-789. |
[1] | WANG Huiying, TANG Yu, DONG Lili, WANG Jing. Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children [J]. Laboratory Medicine, 2023, 38(9): 865-869. |
[2] | SHI Yingying, PAN Fen, SUN Yan, WANG Chun, JIANG Jie, YU Fangyuan, ZHANG Tiandong, QIN Huihong, ZHANG Hong. Nested multiple polymerase chain reaction in rapid diagnosis of meningitis/encephalitis in children [J]. Laboratory Medicine, 2023, 38(8): 766-770. |
[3] | FU Limei, YANG Dan, XU Jin, ZHU Haiyan, ZHU Fenhua. Clinical significance of whole blood trace elements and serum vitamin levels in 6 common skin diseases in children [J]. Laboratory Medicine, 2023, 38(8): 771-775. |
[4] | ZHANG Xin, MA Lijuan. Role of cardiac markers in children [J]. Laboratory Medicine, 2023, 38(6): 505-509. |
[5] | YANG Qiong, XU Fen, LIN Yahui. Clinical application of cardiac troponin determination in pediatric cardiac involvement related diseases [J]. Laboratory Medicine, 2023, 38(6): 510-517. |
[6] | LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong. Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease [J]. Laboratory Medicine, 2023, 38(6): 524-531. |
[7] | WANG Yaling, HUANG Yunli, TIAN Mi, WANG Shunlan, XIAO Li. Relationship between EOS%,CCR3,eotaxin and disease severity in children with acute bronchopneumonia [J]. Laboratory Medicine, 2023, 38(3): 230-234. |
[8] | WU Jinying, FANG Yulian, WANG Wei, HOU Mengzhu, WANG Lu, ZHAO Yu. Clinical characteristics and epidemiological of enterovirus infection in children with acute diarrhea in Tianjin [J]. Laboratory Medicine, 2023, 38(3): 267-271. |
[9] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[10] | HU Shaohua, CHEN Li, ZHAO Meng, MA Zhan, ZHANG Hong. Epidemiological characteristic analysis of Mycoplasma pneumoniae infection in children in Shanghai [J]. Laboratory Medicine, 2023, 38(1): 14-17. |
[11] | WEI Rui, YUAN Xu, TIAN Xuewen, LU Yanjun. Clinical and laboratory characteristics of human metapneumovirus infection children in a Grade A Class 3 hospital in Wuhan [J]. Laboratory Medicine, 2023, 38(1): 18-22. |
[12] | LU Lijuan, XU Jin. Thoughts on whether adenovirus is the cause of the hepatitis of unknown etiology among children recently [J]. Laboratory Medicine, 2022, 37(8): 705-709. |
[13] | AO Jiajia, ZHANG Junfeng, NIE Wenjian, YE Qing. Relationship of fasting C-peptide with nonalcoholic fatty liver disease in children with obesity [J]. Laboratory Medicine, 2022, 37(7): 618-622. |
[14] | PAN Fen, PAN Yuxuan, SHI Yingying, YU Fangyuan, ZHANG Hong. UroQuick rapid urine culture technique for urinary tract infection in children [J]. Laboratory Medicine, 2022, 37(7): 652-656. |
[15] | MENG Shuting, ZHOU Weiping, DAI Huifen, DONG Deping, DONG Yefeng, GE Renmei, WANG Huimin. Evaluation of uncertainty of serum total bilirubin in calibration curve method by Monte Carlo method [J]. Laboratory Medicine, 2022, 37(7): 674-679. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||